Benzoyl-tetrahydropyridine as GlyT-1 inhibitors

Details for Australian Patent Application No. 2005324109 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Norcross, Roger David; Narquizian, Robert; Jolidon, Synese; Pinard, Emmanuel

Agent Spruson & Ferguson

Pub. Number AU-B-2005324109

PCT Pub. Number WO2006/072432

Priority 05100027.1 04.01.05 EP

Filing date 27 December 2005

Wipo publication date 13 July 2006

Acceptance publication date 20 January 2011

International Classifications

C07D 211/70 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/444 (2006.01)

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/072432 Priority application(s): WO2006/072432

23 August 2007 Change of Name(s) of Applicant(s), Section 104

  F.Hoffmann-La Roche AG The name of the applicant has been changed to F. Hoffmann-La Roche AG

20 January 2011 Application Accepted

  Published as AU-B-2005324109

19 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005324110-Substrate material made of polycarbonate for transparent injected-moulded parts

2005324107-Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine D3 antagonists